Renaissance Capital logo

IRMD News

MRI-safe IV maker iRadimed prices IPO at $6.25, above the range

iRadimed, which makes non-magnetic MRI-safe IV infusion pumps, raised $13 million by offering 2.0 million shares at $6.25, above the $5 to $6 range. iRadimed will list on the NASDAQ under the symbol IRMD. Roth Capital acted as sole bookrunner on the deal....read more

11 US IPOs planned for the week of Jul 14

The following IPOs are expected to price this week: CareDx (CDNA), which sells molecular diagnostic tests to monitor heart transplants, plans to raise $50 million by...read more

MRI-safe IV maker iRadimed sets terms for $10 million IPO

iRadimed, which makes non-magnetic MRI-safe IV infusion pumps, announced terms for its IPO on Wednesday. The Winter Park, FL-based company plans to raise nearly $10 million by offering 1.75 million shares at a price range of $5 to $6. At the midpoint of the...read more

MRI-safe IV system maker iRadimed files for a $12 million IPO

iRadimed, which makes non-magnetic IV systems that are safe to use during MRI procedures, filed on Wednesday with the SEC to raise up to $12 million in an initial public offering. The Winter Park, FL-based company, which was founded in 1992 and booked $12...read more

Archived Headlines